Wells Fargo’s Kezar Life Sciences KZR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$26.3K Buy
5,746
+43
+0.8% +$197 ﹤0.01% 5280
2025
Q1
$27.8K Sell
5,703
-474
-8% -$2.31K ﹤0.01% 5148
2024
Q4
$41.5K Sell
6,177
-1,639
-21% -$11K ﹤0.01% 5057
2024
Q3
$60.4K Sell
7,816
-135
-2% -$1.04K ﹤0.01% 4875
2024
Q2
$47.7K Sell
7,951
-1,019
-11% -$6.11K ﹤0.01% 4949
2024
Q1
$80.9K Sell
8,970
-612
-6% -$5.52K ﹤0.01% 4646
2023
Q4
$90.8K Sell
9,582
-2,066
-18% -$19.6K ﹤0.01% 4561
2023
Q3
$139K Buy
11,648
+1,389
+14% +$16.5K ﹤0.01% 4259
2023
Q2
$251K Buy
10,259
+245
+2% +$6K ﹤0.01% 4208
2023
Q1
$313K Buy
10,014
+5,805
+138% +$182K ﹤0.01% 3906
2022
Q4
$296K Sell
4,209
-448
-10% -$31.5K ﹤0.01% 3715
2022
Q3
$400K Sell
4,657
-4,014
-46% -$345K ﹤0.01% 3581
2022
Q2
$717K Sell
8,671
-3,186
-27% -$263K ﹤0.01% 3315
2022
Q1
$1.97M Sell
11,857
-3,055
-20% -$508K ﹤0.01% 3126
2021
Q4
$2.49M Sell
14,912
-10,359
-41% -$1.73M ﹤0.01% 3072
2021
Q3
$2.18M Buy
25,271
+1,079
+4% +$93.2K ﹤0.01% 3418
2021
Q2
$1.31M Sell
24,192
-1,464
-6% -$79.5K ﹤0.01% 3812
2021
Q1
$1.53M Sell
25,656
-5,765
-18% -$343K ﹤0.01% 3694
2020
Q4
$1.64M Buy
31,421
+8,573
+38% +$447K ﹤0.01% 3584
2020
Q3
$1.11M Sell
22,848
-7,842
-26% -$379K ﹤0.01% 3706
2020
Q2
$1.59M Buy
30,690
+23,519
+328% +$1.22M ﹤0.01% 3386
2020
Q1
$312K Sell
7,171
-1,599
-18% -$69.6K ﹤0.01% 4252
2019
Q4
$352K Buy
8,770
+4,577
+109% +$184K ﹤0.01% 4511
2019
Q3
$138K Buy
4,193
+1,105
+36% +$36.4K ﹤0.01% 4953
2019
Q2
$238K Buy
3,088
+2,321
+303% +$179K ﹤0.01% 4707
2019
Q1
$136K Buy
767
+509
+197% +$90.3K ﹤0.01% 4934
2018
Q4
$61K Buy
258
+25
+11% +$5.91K ﹤0.01% 5187
2018
Q3
$50K Buy
+233
New +$50K ﹤0.01% 5299